Kronos Bio Price To Book vs. Net Income
| KRON Stock | USD 0.95 0.01 1.04% |
For Kronos Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kronos Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kronos Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kronos Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kronos Bio over time as well as its relative position and ranking within its peers.
Kronos |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Revenue Per Share 0.143 | Quarterly Revenue Growth 0.442 | Return On Assets (0.28) | Return On Equity (0.63) |
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kronos Bio Net Income vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Kronos Bio's current stock value. Our valuation model uses many indicators to compare Kronos Bio value to that of its competitors to determine the firm's financial worth. Kronos Bio is rated fourth overall in price to book category among its peers. It is rated third overall in net income category among its peers . Kronos Bio reported last year Net Loss of (112.67 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kronos Bio's earnings, one of the primary drivers of an investment's value.Kronos Net Income vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Kronos Bio |
| = | 0.52 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Kronos Bio |
| = | (112.67 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Kronos Net Income Comparison
Kronos Bio is currently under evaluation in net income category among its peers.
Kronos Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Kronos Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kronos Bio will eventually generate negative long term returns. The profitability progress is the general direction of Kronos Bio's change in net profit over the period of time. It can combine multiple indicators of Kronos Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 19 K | 19.9 K | |
| Net Interest Income | 9 M | 9.5 M | |
| Interest Income | 9 M | 9.5 M | |
| Operating Income | -121.8 M | -127.9 M | |
| Net Loss | -119.1 M | -125.1 M | |
| Income Before Tax | -112.7 M | -118.3 M | |
| Total Other Income Expense Net | 9.2 M | 9.6 M | |
| Net Loss | -119.9 M | -125.9 M | |
| Net Loss | -112.7 M | -118.3 M | |
| Income Tax Expense | 4.7 M | 5 M | |
| Non Operating Income Net Other | 4.5 M | 4.7 M | |
| Change To Netincome | 37 M | 21.7 M | |
| Net Loss | (1.95) | (2.05) | |
| Income Quality | 0.70 | 0.83 | |
| Net Income Per E B T | 0.87 | 0.73 |
Kronos Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Kronos Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kronos Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kronos Bio's important profitability drivers and their relationship over time.
Use Kronos Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kronos Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will appreciate offsetting losses from the drop in the long position's value.Kronos Bio Pair Trading
Kronos Bio Pair Trading Analysis
The ability to find closely correlated positions to Kronos Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kronos Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kronos Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kronos Bio to buy it.
The correlation of Kronos Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kronos Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Kronos Bio position
In addition to having Kronos Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Companies from entertainment industry including show business, news and media. The Entertainment theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
To fully project Kronos Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kronos Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kronos Bio's income statement, its balance sheet, and the statement of cash flows.